Rock Springs Capital Management LP Adaptive Biotechnologies Corp Transaction History

Rock Springs Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$30.02 - $39.87 $19.5 Million - $25.9 Million	-650,000 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$37.26 - $67.74 $558,900 - $1.02 Million	15,000 Added 2.36%	650,000 $26.2 Million
Q3 2020 Nov 16, 2020	BUY	$35.79 - $48.81 $2.15 Million - $2.93 Million	60,000 Added 10.43%	635,000 $30.9 Million
Q2 2020 Aug 14, 2020	BUY	$24.95 - $48.38 $748,500 - $1.45 Million	30,000 Added 5.5%	575,000 $27.8 Million
Q3 2019 Nov 14, 2019	SELL	$30.31 - $53.51 $1.67 Million - $2.94 Million	-55,000 Reduced 9.17%	545,000 $16.8 Million
Q2 2019 Aug 14, 2019	BUY	$40.3 - $48.3 $24.2 Million - $29 Million	600,000 New	600,000 $29 Million

201

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $670M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Rock Springs Capital Management LP with notifications on news.